Hemo Organic Ltd

Mon 24/08/2026,16:1:0 | BSE : HEMORGANIC

₹18.91-0.99 (-4.97%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 18.91

Previous Close

₹ 19.90

Volume

1

Mkt Cap ( ₹ Cr)

₹ 6.55

High

₹ 18.91

Low

₹ 18.91

52 Week High

₹ 24.42

52 Week Low

₹ 8.12

Book Value Per Share

₹ 0.16

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Hemo Organic Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Hemo Organic Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Hemo Organic - Intimation Of E-Voting, Book Closure/Closure Of Transfer Books And Cut-Off Date For The Purpose Of E-Voting Pu

    14 Aug 2026, 6:36PM Intimation of Book Closure
  • Hemo Organic - Reg. 34 (1) Annual Report.

    13 Aug 2026, 7:32PM Submission of Annual Report for the Financial Year 2025-26
  • Hemo Organic - Submission Of Annual Report For Financial Year 2025-26 Along With The Notice Convening 34Th Annual General Mee

    13 Aug 2026, 7:30PM Submission of Annual Report for the Financial Year 2025-26
  • Hemo Organic - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

    13 Aug 2026, 7:26PM Appointment of Statutory Auditor
  • Hemo Organic - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. Thursday, 13Th August, 2026

    13 Aug 2026, 7:24PM Outcome of the Board Meeting held today i.e. Thursday, 13th August, 2026
  • Hemo Organic - Announcement under Regulation 30 (LODR)-Retirement

    13 Aug 2026, 7:20PM Announcement under Regulation 30 (LODR) - Completion of Tenure of Statutory Auditor of Company
  • Hemo Organic - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    4 Aug 2026, 6:45PM Appointment of Secretarial Auditor and Internal Auditor
  • Hemo Organic - Board Meeting Outcome for For The Meeting To Be Held Today, I.E. 04Th August, 2026

    4 Aug 2026, 6:32PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that meeting of the Board
  • Hemo Organic has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    18 Jul 2026, 7:00PM As of June 2026, 16.85% is owned by Indian Promoters and 83.15% by Public. <p align=justify> Top two Promoters holding highest number of shares of Hem
  • Hemo Organic - Submission Of Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended On 30Th June

    15 Jul 2026, 6:00PM Submission of Un-audited financial results along with limited review report for the quarter ended on 30th June, 2026
  • Hemo Organic - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E., Wednesday, 15Th July, 2026

    15 Jul 2026, 5:54PM Outcome of Board Meeting held today i.e., Wednesday, 15th July, 2026.
  • Hemo Organic - Outcome Of The Board Meeting Held Today I.E., Wednesday, 15Th July, 2026

    15 Jul 2026, 5:46PM Submission of Un-audited financial Results of the company for the quarter ended as on 30th June, 2026 along with Limited Review Report.
  • Hemo Organic - Board Meeting Intimation for The Meeting To Be Held On Wednesday, 15Th July, 2026

    10 Jul 2026, 6:45PM Hemo Organic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/07/2026 ,inter alia, to consider and app
  • Hemo Organic - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    10 Jul 2026, 5:04PM Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2026

Key fundamentals

Evaluate the intrinsic value of Hemo Organic Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 2.8735 1.328 0.9223 -0.016 0.0384
Liabilities 2.8735 1.328 0.9223 -0.016 0.0384
Equity 3.4659 3.4659 3.4659 3.4659 3.4659
Gross Profit -0.4997 -0.0443 -0.2462 -0.0546 -0.0622
Net Profit -0.7781 0.1639 -0.2641 -0.0546 -0.0623
Cash From Operating Activities -1.4581 -0.3617 -1.1904 0.1073 -0.0044
NPM(%) -83.75 6.78 -1179.01 -1146.2 -913.14
Revenue 0.929 2.4143 0.0224 0.0047 0.0068
Expenses 1.4287 2.4586 0.2686 0.0594 0.069
ROE(%) -1325.55 279.21 -449.91 -93.14 -106.24

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Hemo Organic Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1612.00 -1.70 14.23 17.17 1071.07 0.43
Sharda Cropchem Ltd 780.05 -1.06 11.21 170.61 754.66 1.93
Ram Minerals and Chemicals Ltd 0.49 0.00 49.00 389.15 -0.09 0.00
Amines and Plasticizers Ltd 182.25 0.33 25.72 104.04 331.99 0.28

Company Info

Dinesh Allorga Limited was incorporated on August 28, 1992 as a Public limited Company under the Companies Act, 1956 and received its certificate for commencement of business on the same dte. The company is setting up a new project to manufacture 2,6 Di Chloro Aniline which is used widely as an intermediate in bulk drugs/pharmaceuticals and Para Chloro Meta Cresol which is used in the leather industry. The project is being set up at a project cost of Rs.447 lace near Khambhat, Dist. Kheda, Gujarat. The installed capacity for 2,6 Dichloro aniline would be 110 metric tonnes per annum and that for para Chloro Meta Cresol would be 220 metric tonnes per annum. Promoters The company has been promoted by technocrats having relevant experience. The principal promoters are Dr. Dineshbhai S Patel, Dr. Kantilal S Patel, Dr. Rajnikant M. Patel. Subsidiary company There are no subsidiary companies under section 370(1B) of The Act. 2013 -Company has changed its name from Dinesh Allorga Limited to Hemo Organic Limited.

Dinesh Allorga Limited was incorporated on August 28, 1992 as a Public limited Company under the Companies Act, 1956 and received its certificate for commencement of business on the same dte. The company is setting up a new project to manufacture 2,6 Di Chloro Aniline which is used widely as an intermediate in bulk drugs/pharmaceuticals and Para Chloro Meta Cresol which is used in the leather industry. The project is being set up at a project cost of Rs.447 lace near Khambhat, Dist. Kheda, Gujarat. The installed capacity for 2,6 Dichloro aniline would be 110 metric tonnes per annum and that for para Chloro Meta Cresol would be 220 metric tonnes per annum. Promoters The company has been promoted by technocrats having relevant experience. The principal promoters are Dr. Dineshbhai S Patel, Dr. Kantilal S Patel, Dr. Rajnikant M. Patel. Subsidiary company There are no subsidiary companies under section 370(1B) of The Act. 2013 -Company has changed its name from Dinesh Allorga Limited to Hemo Organic Limited.

Parent Organisation

Hemo Organic Ltd.

Founded

28/08/1992

Managing Director

Mr.Vishwambar Kameshwar Singh

NSE Symbol

FAQ